Table 3.
Associations between HSV types 1 or 2 and cancer status-NHANES 1999–2014
| HSV1 | aOR | (95% CI) | P value |
|---|---|---|---|
| Any cancer | 1.32 | (0.97–1.79) | 0.07 |
| Breast cancer | 2.04 | (0.78–5.37) | 0.14 |
| Cervical cancer | 1.04 | (0.60–1.80) | 0.89 |
| Ovarian cancer | 1.57 | (0.37–6.64) | 0.54 |
| Uterine cancer | 6.03 | (1.52–23.87) | 0.01 |
| HSV2 | aOR | (95% CI) | P value |
| Any cancer | 1.47 | (1.01–2.14) | 0.04 |
| Breast cancer | 0.69 | (0.20–2.40) | 0.56 |
| Cervical cancer | 1.72 | (1.06–2.79) | 0.03 |
| Ovarian cancer | 1.56 | (0.50–4.94) | 0.44 |
| Uterine cancer | 3.49 | (1.03–11.85) | 0.04 |
Abbreviations: HSV1, herpes simplex virus type 1; HSV2, herpes simplex virus type 2; aOR, Adjusted odds ratio; CI, confidence interval; NHANES, National Health and Nutrition Examination Survey
Model was adjusted for age, education, race, poverty income ratio, body mass index, smoking status, alcohol-use status and HIV status